HIVWomen
Meeting category
Date(s)
12 Apr 2024 - 13 Apr 2024
Location
Washington D.C., United States
Meeting type
Hybrid Meeting
Organizer
Titanium Level Sponsor
Sponsor logos
NIH 2023

International Workshop on HIV & Women 2024

Related Enduring Materials

Enduring Materials

Download Program

Download Program Book

Download Abstract Book

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

Session 1: Increasing the Burden: Impact of Global Crises on Women Living with HIV -
Overview of the Impact of the Global Climate Change Crisis on Infectious Diseases
Siegbert Rieg, MD
University Medical Center Freiburg, Germany
Refugees/Women Living with HIV on the Move - Implications for Management
Chioma Nnaji, MEd, MPH
Multicultural AIDS Coalition (MAC), United States
Session 2: Debate: ART Causes Hypertension in HIV -
Healthcare Provider: For the Proposition
Claudia Cortes, MD
University of Chile, Chile
Healthcare Provider: Against the Proposition
Jürgen Rockstroh, MD
University of Bonn, Germany
Community Representative: For the Proposition
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Community Representative: Against the Proposition
Lucy Hutchinson
The Sussex Beacon, United Kingdom
NIH/OAR Supported Symposium: Breaking the Barriers to the Prevention and Treatment of HIV among Women -
Opening & Welcome
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
Kathleen Powis, MD
Harvard Medical School / Massachusetts General Hospital, United States
Mary Glenshaw, PhD, MPH
NIH Office of AIDS Research (OAR), United States
Avoiding Body Weight Bias in Healthcare for Women with HIV
Julie Schexnayder
University of Alabama at Birmingham, United States
Response
Amanda Willig, PhD, RD
University of Alabama at Birmingham, United States
HIV, PrEP Use and Related Biases among Adolescent Girls and Young Women in South Africa
Krishnaveni Surina Reddy, MMedSci
Wits Reproductive Health and HIV Institute (Wits RHI), South Africa
Response
Christina Psaros, PhD
Harvard Medical School / Massachusetts General Hospital, United States
PrEP Equity for Black Women - A "Dream Deferred” Becoming Reality
Latesha Elopre, MD, MSPH
University of Alabama at Birmingham, United States
Response
Abby Charles, MPH
Institute for Public Health Innovation (IPHI), United States
Closing
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
End of Symposium
Session 3: HIV and Co-Infections -
HIV and TB
Judith Kose, MD, PhD
Africa CDC, Eastern Africa Regional Coordinating Centre, Kenya
HPV and Cervical/Anal Cancer in Women with HIV
Deborah Money, MD, FRCSC
University of British Columbia, Canada
14:10
HIV and Long COVID
Simiso Sokhela, BSc, MBChB, Dip HIV Man
Ezintsha, University of the Witwatersrand, South Africa
#1 - Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence and Synergies with Human T-lymphotropic Virus-1
James Kangethe
Kenya
#2 - Seroprevalence and Correlates of Co-infection With HIV and Active Syphilis Among Women in Six Sub-Saharan African Countries: Results From Population-Based HIV Impact Assessments (PHIAs)
Derrick Bary Abila
Uganda
#3 - Roll Out of Cervical Cancer Screening and Treatment Program; The Uganda’s Success Story
Josephine Ninsiima
Uganda
Industry Supported Symposium: People First Language - Why it Matters -
Introduction
Ama Appiah, BSc, MRPharmS
ViiV Healthcare, United Kingdom
What Is People-First Language, Why Does It Matter, and What Does It Mean for the HIV Community?
Yvonne Gilleece, MB, BCh, BAO
Brighton & Sussex Medical School and University Hospitals Sussex NHS Foundation Trust, United Kingdom
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Marvelous Muchenje, BSW, MSc, PhD
ViiV Healthcare, Canada
End of the Symposium
Session 4: Pregnancy and Breastfeeding -
Infant Feeding Choices for Parents Living With HIV: Updates From the INFORM+ Forum Group
Natasha Davies, MD
Anova Health Institute, South Africa
8:50
Update on Use of Antiretrovirals in Pregnancy
Angela Colbers, PhD
Radboudumc, the Netherlands
#4 - Case Series of Women With HIV Who Breastfed
William Short
United States
#5 - Risk Factors for Preterm Birth in Pregnant Women Living With HIV: A 25-Year Analysis of the British Columbia Perinatal HIV Database
Jeffrey Man Hay Wong
Canada
#6 - Birth Defects Following Dolutegravir Transition among Women Delivering at Surveillance Sites in Eswatini
Philisiwe Ntombenhle Khumalo
Swaziland
#7 - The Health Outcomes Around Pregnancy and Exposure to HIV/ARVs (HOPE) Study: A Prospective Cohort of Reproductive-Aged Women Living With HIV
Deborah Kacanek
United States
Session 5: Where Do We Stand: Women Aging with HIV - from Research to Service Delivery -
Service Delivery for Women Aging with HIV
Luxey Sirisegaram, MD
University Health Network and Sinai Health Systems from University of Toronto, Canada
Cardiovascular Risk for Women - Data from the Reprieve Study
Sara E. Looby, PhD, ANP-BC, FAAN
Harvard Medical School / Massachusetts General Hospital, United States
Overview of Cardiovascular Diseases in Women
#8 - The CD38-NAD+ Axis Mediates a Hyperinflammatory State in WLWH
Poonam Mathur
United States
#9 - Sex Disparities in Geriatric Syndromes among People 50 Years or Older Receiving Care For HIV Infection in Mexico (2012-2017)
Yanink Caro-Vega
Mexico
Session 6: Abstract-Driven Presentations: Strategies for Prevention -
#10 - Antiretroviral Therapy Adherence Strategies for Women with HIV in the Postpartum Period
Florence Momplaisir
United States
#11 - EmpowerHER: Black Women's Reasons for HIV Prevention
Dana Williams
United States
#12 - HIV Sero-Conversions Among Adolescent Girl and Young Female Dapivirine Vaginal Ring (DPV-R) Users: Early Learnings From a Demonstration Project in Zimbabwe
Jabulani Mavudze
Zimbabwe
#13 - Factors Associated with Unawareness of HIV Status and Recency of HIV Infections among Women Living with HIV: Findings from a Population-Based Survey in Thirteen African Countries
Irene Mbabazi
Uganda
Session 7: Comorbidities and Women -
Appropriate Use of Hormonal Replacement Therapy During Menopause
Karoline Aebi-Popp, PD, MD, MSc
University Hospital Bern, Switzerland
Metabolic Complications - The Role of the New Weight Reduction Therapies
Todd Brown, MD, PhD
Johns Hopkins University, United States
Comorbidities in Trans Women
Kate Nambiar, MD, PhD
Terrence Higgins Trust, United Kingdom
Language
Ratings previous edition
I would recommend this workshop to my peers
4.8
(113)
Content was presented clearly
4.5
Content is relevant to my practice
4.5